Literature DB >> 2296763

Sensitive periods for lead-induced behavioral impairment (nonspatial discrimination reversal) in monkeys.

D C Rice1, S G Gilbert.   

Abstract

A total of 52 nursery-reared monkeys (Macaca fascicularis) were dosed orally with 1.5 mg/kg/day of lead on one of four dosing regimens (13 monkeys/group): Group 1, vehicle only; Group 2, dosed with lead continuously from birth; Group 3, dosed with lead from birth to 400 days of age and vehicle thereafter; and Group 4, dosed with vehicle from birth to 300 days of age and lead thereafter. This dosing regimen allowed evaluation of differential infant vulnerability as well as reversibility of the behavioral toxicity of lead. Blood lead concentrations averaged 3-6 micrograms/dl when monkeys were not being exposed to lead, 32-36 micrograms/dl when being dosed with lead and having access to infant formula, and 19-26 micrograms/dl during lead exposure after weaning from infant formula. When monkeys were 5-6 years old, they were tested on a series of nonspatial discrimination reversal tasks: form, form with irrelevant color cues, color with irrelevant form cues, and alternating form and color. Group 2 exhibited the greatest degree of impairment compared to controls. Group 4 also exhibited impaired performance, although less marked than that of Group 2. Group 3 was not impaired on this series of tasks. These results confirm findings observed in other monkeys exposed continuously to lead and suggest that while exposure beginning after infancy produces impairment, exposure during infancy as well exacerbates the effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296763     DOI: 10.1016/0041-008x(90)90087-b

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  9 in total

1.  The attention set-shifting test is sensitive for revealing sex-based impairments in executive functions following developmental lead exposure in rats.

Authors:  Lorenz S Neuwirth; Sidrah Masood; David W Anderson; Jay S Schneider
Journal:  Behav Brain Res       Date:  2019-03-13       Impact factor: 3.332

Review 2.  Behavioral effects of lead: commonalities between experimental and epidemiologic data.

Authors:  D C Rice
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

Review 3.  Lessons for neurotoxicology from selected model compounds: SGOMSEC joint report.

Authors:  D C Rice; A M Evangelista de Duffard; R Duffard; A Iregren; H Satoh; C Watanabe
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

4.  Experimental manipulations blunt time-induced changes in brain monoamine levels and completely reverse stress, but not Pb+/-stress-related modifications to these trajectories.

Authors:  D A Cory-Slechta; M B Virgolini; A Rossi-George; D Weston; M Thiruchelvam
Journal:  Behav Brain Res       Date:  2009-07-22       Impact factor: 3.332

5.  Developmental stress and lead (Pb): Effects of maternal separation and/or Pb on corticosterone, monoamines, and blood Pb in rats.

Authors:  Robyn M Amos-Kroohs; Devon L Graham; Curtis E Grace; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Charles V Vorhees; Michael T Williams
Journal:  Neurotoxicology       Date:  2016-03-02       Impact factor: 4.294

Review 6.  Childhood Lead Exposure and Adult Neurodegenerative Disease.

Authors:  Aaron Reuben
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 7.  Lead and PCBs as risk factors for attention deficit/hyperactivity disorder.

Authors:  Paul A Eubig; Andréa Aguiar; Susan L Schantz
Journal:  Environ Health Perspect       Date:  2010-09-09       Impact factor: 9.031

Review 8.  Parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys.

Authors:  D C Rice
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

Review 9.  Neurotoxicity of lead, methylmercury, and PCBs in relation to the Great Lakes.

Authors:  D C Rice
Journal:  Environ Health Perspect       Date:  1995-12       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.